YAP1 and Alzheimer disease: A number of studies suggest that hyperactivation of the Hippo pathway – characterized by increased MST1/2 and LATS1/2 activation, decreased YAP levels, and increased YAP phosphorylation and nuclear exclusion – occurs in AD.